"We’ve assembled the ultimate bench of experts to be the right partner for our diverse portfolio of healthcare companies and entrepreneurs," said Jay Goss, General Partner of Wavemaker 360. We are excited to carry out Wavemaker 360’s mission to invest and support the next generation of visionaries in healthcare." "With the closing of Fund II, we’re more driven than ever about fostering a future where healthcare companies, entrepreneurs, professionals and patients are able to flourish in ways nobody could previously conceive. We are seeking entrepreneurs stepping up with innovative solutions at a rapid pace," said John Nackel, PhD, Founder and General Partner of Wavemaker 360. "It is a pivotal time in the healthcare industry, which is experiencing massive disruption, workforce challenges, and significant pandemic-related recovery. One Fund II exit has already taken place, at an accelerated pace, with Carbon Health acquiring Alertive in October 2021. Of those companies, 15 are Fund II investments. The fund currently has $85MM+ assets under management (AUM) across two funds, and in less than four years has invested into 45 healthcare companies across the U.S., Canada, Europe and Singapore. that discovers, vets and invests solely in healthcare startups at the seed funding stage. Since its inception in 2018, Wavemaker 360 stands apart as one of the few venture funds in the U.S.
and to a lesser extent international), with several investments already made into some of the most compelling healthcare start-ups in the areas of health-tech, digital health, medical device, telehealth, artificial intelligence, pharma-tech, science and marketplaces. The goal for Fund II is to invest into 40-50 early-stage companies (U.S. Fund II’s Limited Partners (LPs) include hundreds of healthcare organizations and prominent healthcare executives across the United States, as well as some international investors. PASADENA, Calif., June 09, 2022-( BUSINESS WIRE)- Wavemaker Three-Sixty Health (Wavemaker 360), the nation’s leading venture fund focused on early-stage (primarily seed) healthcare disruptors and innovators, closes its Fund II at $64 million, surpassing its first fund nearly four times over.
Quadrupling its first fund, Wavemaker 360 solidifies its status as the leading seed-stage healthcare pure-play venture fund in the United States
0 kommentar(er)
